Medco Acquires United BioSource for Post-Approval Research Capabilities
Heather Cartwright
Abstract
Medco Health Solutions is buying United BioSource, a company that undertakes post-approval research, for US$730 M to expand its personalised medicine research operations.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.